nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Overview of the Orphan Medicines Market in Turkey
|
Koçkaya, Güvenç |
|
2014 |
4 |
C |
p. 47-52 6 p. |
artikel |
2 |
Copyright/Subscription
|
|
|
2014 |
4 |
C |
p. iv- 1 p. |
artikel |
3 |
Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition
|
Marković, Veroljub |
|
2014 |
4 |
C |
p. 87-94 8 p. |
artikel |
4 |
Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model
|
Elsisi, Gihan H. |
|
2014 |
4 |
C |
p. 24-30 7 p. |
artikel |
5 |
Cost-effectiveness versus Cost-Utility Analyses: What Are the Motives Behind Using Each and How Do Their Results Differ?—A Polish Example
|
Jakubiak-Lasocka, Joanna |
|
2014 |
4 |
C |
p. 66-74 9 p. |
artikel |
6 |
Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel
|
Simon-Tuval, Tzahit |
|
2014 |
4 |
C |
p. 41-46 6 p. |
artikel |
7 |
Editorial Board
|
|
|
2014 |
4 |
C |
p. i- 1 p. |
artikel |
8 |
Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis
|
Boubouchairopoulou, Nadia |
|
2014 |
4 |
C |
p. 82-86 5 p. |
artikel |
9 |
Guide for Authors
|
|
|
2014 |
4 |
C |
p. I-II nvt p. |
artikel |
10 |
Health Care Financing in Ethiopia: Implications on Access to Essential Medicines
|
Ali, Eskinder Eshetu |
|
2014 |
4 |
C |
p. 37-40 4 p. |
artikel |
11 |
Health Economic Data Requirements and Availability in the European Union: Results of a Survey Among 10 European Countries
|
Skoupá, Jana |
|
2014 |
4 |
C |
p. 53-57 5 p. |
artikel |
12 |
Health Facility Cost of Buruli Ulcer Wound Treatment in Ghana: A Case Study
|
Asare, Kofi Hene |
|
2014 |
4 |
C |
p. 14-18 5 p. |
artikel |
13 |
Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe
|
Golicki, Dominik |
|
2014 |
4 |
C |
p. 19-23 5 p. |
artikel |
14 |
Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece: Focusing on Price Reductions and Cost-Sharing Rates
|
Olga, Siskou Ch. |
|
2014 |
4 |
C |
p. 107-114 8 p. |
artikel |
15 |
Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes
|
Vokó, Zoltán |
|
2014 |
4 |
C |
p. 31-36 6 p. |
artikel |
16 |
Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic: Cost-of-Illness Study Based on Disease Severity
|
Klimeš, Jiří |
|
2014 |
4 |
C |
p. 75-81 7 p. |
artikel |
17 |
Publisher’s Note
|
|
|
2014 |
4 |
C |
p. 8- 1 p. |
artikel |
18 |
Reviewer Acknowledgement
|
|
|
2014 |
4 |
C |
p. 117-118 2 p. |
artikel |
19 |
Social Cost of Substance Abuse in Russia
|
Potapchik, Elena |
|
2014 |
4 |
C |
p. 1-5 5 p. |
artikel |
20 |
Table of Contents
|
|
|
2014 |
4 |
C |
p. ii-iii nvt p. |
artikel |
21 |
The Cost of Melanoma and Kidney, Prostate, and Ovarian Cancers in Russia
|
Ignatyeva, Victoria I. |
|
2014 |
4 |
C |
p. 58-65 8 p. |
artikel |
22 |
The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary
|
Oberfrank, Ferenc |
|
2014 |
4 |
C |
p. 6-7 2 p. |
artikel |
23 |
Use of the EQ-5D Instrument and Value Scale in Comparing Health States of Patients in Four Health Care Programs among Health Care Providers
|
Rupel, Valentina Prevolnik |
|
2014 |
4 |
C |
p. 95-99 5 p. |
artikel |
24 |
What Are the Challenges in Conducting Cost-of-Illness Studies?
|
Greenberg, Dan |
|
2014 |
4 |
C |
p. 115-116 2 p. |
artikel |
25 |
Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis
|
Kruntorádová, Klára |
|
2014 |
4 |
C |
p. 100-106 7 p. |
artikel |